Skip to main content

Table 1 Comparison of pathological and clinical features of patients with triple-negative and non-triple-negative breast cancer

From: Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer

Factors

Triple-negative (%)

Non-triple-negative (%)

χ 2

P

Age (years)

    

  <40

8 (11.9)

5 (4.7)

3.148

0.076

  ≥40

59 (88.1)

102 (95.3)

  

Primary tumor size (diameter)

    

  d<2 cm

17 (25.4)

14 (13.1)

4.659

0.097

  2 ≤ d<5 cm

43 (64.2)

76 (71.0)

  

  d ≥5

7 (10.4)

17 (15.9)

  

Grade

    

  I and II

48 (71.6)

73 (80.0)

5.764

0.039

  III

19 (28.4)

34 (20.0)

  

Axillary node status

    

  Negative

25 (37.4)

72 (67.3)

4.078

0.048

  Positive

42 (62.6)

35 (32.7)

  

TNM stage

    

  I

13 (19.4)

16 (15.0)

6.374

0.050

  II

42 (62.7)

84 (76.6)

  

  III

12 (17.9)

9 (8.4)

  

VM

    

  No

43 (64.2)

88 (82.2)

5.237

0.002

  Yes

24 (35.8)

19 (17.8)

 Â